- Home
- / Adaptimmune
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Adaptimmune financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.7
2024-10-29
Market Capitalization
$188.5 M
2024-10-29
Revenue
$178 M
FY, 2024
CreditSafe Score
?
Score changed on May 13, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.2M | 37.8M | 59.5M | 1.1M | 4.0M | 6.1M | 27.1M | 60.3M | 178.0M |
| Cost of goods sold | 70.0K | ||||||||
| Gross profit | 178.0M | ||||||||
| Gross profit margin, % | 100.0% | ||||||||
| General and administrative expense | 73.5M | 87.3M | |||||||
| Operating expense total | 246.7M | ||||||||
| EBIT | (72.8M) | (80.7M) | (82.4M) | (139.8M) | (133.4M) | (162.2M) | (164.0M) | (139.7M) | (68.8M) |
| EBIT margin, % | -512.7% | -213.2% | -138.4% | -12457.2% | -3370.5% | -604.0% | -38.6% | ||
| Investment income | 6.6M | ||||||||
| Interest income | 2.2M | 2.8M | 2.8M | ||||||
| Interest expense | 1.1M | 2.1M | |||||||
| Pre tax profit | (70.7M) | (69.7M) | (95.0M) | (136.9M) | (129.9M) | (157.3M) | (163.0M) | (112.5M) | (67.2M) |
| Income tax expense | 892.0K | 451.0K | 497.0K | 242.0K | 162.0K | 791.0K | 2.5M | 1.3M | 3.6M |
| Net Income | (71.6M) | (70.1M) | (95.5M) | (137.2M) | (130.1M) | (158.1M) | (165.5M) | (113.9M) | (70.8M) |
| EPS | (0.2) | 0.0 |